Choriogonadotropin-alfa/follitropin-alfa/triptorelin

In: Reactions Weekly · 2021 · vol. 1867(1) , pp. 115 · doi:10.1007/s40278-021-00175-0 · W4210316301
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-07+body, 2026-07-17

This article discusses the potential complications of ovarian stimulation using choriogonadotropin-alfa, follitropin-alfa, and triptorelin, specifically in the context of thoracic endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-17 · read from full text

The paper reports complications associated with ovarian stimulation in the setting of thoracic endometriosis, described as a French-language source and summarized in an accessible format. It highlights that ovarian stimulation can be linked to thoracic endometriosis–related complications, but the summary does not provide detailed methodological specifics beyond the case/report nature. The main limitation, as presented here, is that the available text is a summary/translation rather than the full original article details, limiting the ability to assess study design and extent of evidence. Relevance to endometriosis: it specifically addresses endometriosis complications during ovarian stimulation in thoracic endometriosis, though the corpus focuses on endometriosis and adenomyosis more broadly and the topic is thoracic rather than uterine/adenomyotic disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 571 characters · extracted from oa-doi-fallback · click to expand
Reference Pellerin M, et al. [Ovarian stimulation: Complications caused by thoracic endometriosis]. [French]. Gynecologie Obstetrique Fertilite et Senologie 48: 400-403, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1016/j.gofs.2020.01.011 [French; summarised from a translation] Rights and permissions About this article Cite this article Choriogonadotropin-alfa/follitropin-alfa/triptorelin. Reactions Weekly 1867, 115 (2021). https://doi.org/10.1007/s40278-021-00175-0 Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s40278-021-00175-0

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK